Director of Corporate & Business Development (Valuation & Analytics)

Scholar Rock's Corporate and Business Development (C&BD) team is responsible for Corporate Strategy, Corporate Development, Business Development, Inorganic Value Creation, maximizing pipeline progress, de-risking, and non-dilutive financing.

Reporting to the CBO, this role focuses on leading financial assessments and valuations for business development transactions such as in-licensing, out-licensing, mergers, or co-development partnerships. The role involves working closely with the CBO and cross-functional teams (Finance, R&D, Commercial, Legal) to develop detailed financial models and forecasts, supporting the strategic evaluation of potential deals. This role represents BD efforts and leading short-term cross-functional teams in a matrix environment.

• Valuation Modeling: Building and managing complex valuation models, including discounted cash flow (DCF), net present value (NPV), and scenario-based analysis for Projects, Pipeline, Company, etc.
• Cross-functional Collaboration: Partnering with teams to gather data and align on key assumptions for deal valuation and execution.
• Deal Analytics: Analyzing financial terms, assessing deal drivers, risks, and opportunities, and preparing reports for senior management and investment committees.
• Post-deal Analysis: Supporting ongoing evaluation of deal performance, ensuring alignment with the company's financial goals, and conducting impairment tests when necessary.
• Industry and Market Analytics: Keeping up to date on analyst/broker reports and trends of value and deal comps in key markets and development sectors pertinent to SRRK.
• Working with the CBO and Finance to manage external banker, accounting, and audit relationships and deliverables
• Preparation of business documents, executive and board presentations concerning deal analytics, valuation analysis, and in partnership with Finance pro forma financial modeling
• Coordinate with CBO and executive management for business development strategy and strategic planning development

• 10+ years of experience in the pharmaceutical/biotech industry, with a focus on financial modeling and business development transactions.
• Proven expertise in managing complex, global deals.
• Strong knowledge of the drug development and commercialization process, as well as industry trends and competitive landscapes.
• Analytic and strategic thinking, solid decision-making skills in the face of imperfect data
• Extraordinary organizational skills, including demonstrated prioritization skills in a rapidly changing environment
• Excellent communication skills for presenting financial insights to both technical and non-technical stakeholders